Electrophysiologic effects of ethmozin in patients with ventricular tachycardia

This publication has 9 references indexed in Scilit:

• Ethmozin therapy for malignant ventricular arrhythmia
  The American Journal of Cardiology, 1982
• Ethmozin shown effective in reducing chronic high frequency ventricular arrhythmia: Results of a prospective, controlled trial
  The American Journal of Cardiology, 1982
• Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: Identification of drugs that exacerbate tachycardia and potential mechanisms
  American Heart Journal, 1982
• Amiodarone
  New England Journal of Medicine, 1981
• Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias.
  Circulation, 1981
• Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.
  Circulation, 1980
• Ethmozin: A new antiarrhythmic agent developed in the USSR. Efficacy and tolerance
  American Heart Journal, 1979
• Electrophysiological effects of ethmozin on canine myocardium
  Cardiovascular Research, 1979
• Effects of the phenothiazine analog, EN-313, on ventricular arrhythmias in the dog
  European Journal of Pharmacology, 1977